• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease.

作者信息

Krag Aleksander, Wiest Reiner, Albillos Agustín, Gluud Lise Lotte

机构信息

Department of Gastroenterology, Hvidovre University Hospital, Faculty of Health Sciences, Copenhagen University, Hvidovre, Copenhagen, Denmark.

出版信息

Gut. 2012 Jul;61(7):967-9. doi: 10.1136/gutjnl-2011-301348. Epub 2012 Jan 10.

DOI:10.1136/gutjnl-2011-301348
PMID:22234982
Abstract
摘要

相似文献

1
The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease.窗口期假说：β受体阻滞剂的血流动力学和非血流动力学效应可改善肝硬化患者在疾病某个窗口期的生存率。
Gut. 2012 Jul;61(7):967-9. doi: 10.1136/gutjnl-2011-301348. Epub 2012 Jan 10.
2
Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.在基于血流动力学标准被归类为早期良好应答者的肝硬化患者中，长期药物治疗期间门静脉高压恶化的临床意义。
J Hepatol. 2010 Jan;52(1):45-53. doi: 10.1016/j.jhep.2009.10.014. Epub 2009 Oct 23.
3
How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers.如何预防静脉曲张出血：灰色地带——非选择性β受体阻滞剂的情况
Gastroenterology. 2007 Dec;133(6):2029-36. doi: 10.1053/j.gastro.2007.10.028. Epub 2007 Oct 22.
4
Blind beta blockade.盲目β受体阻滞剂治疗
Hepatology. 2001 Oct;34(4 Pt 1):847-8. doi: 10.1002/hep.510340434.
5
[Beta-blockers in the prevention of the rupture of esophageal varices. A meta-analysis].[β受体阻滞剂预防食管静脉曲张破裂：一项荟萃分析]
Med Interna. 1992;44(2-4):28-33.
6
Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.β受体阻滞剂用于预防肝硬化门静脉高压症患者食管静脉曲张出血。文献综述
Eur J Med Res. 1996 Jun 25;1(9):407-16.
7
Prophylaxis with beta blockers as a performance measure of quality health care in cirrhosis.使用β受体阻滞剂进行预防作为肝硬化优质医疗保健的一项绩效指标。
Gastroenterology. 2006 Mar;130(3):1005-7. doi: 10.1053/j.gastro.2005.11.055.
8
[Role of beta blockers in preventing hemorrhages from esophageal varices. A hemodynamic study].[β受体阻滞剂在预防食管静脉曲张出血中的作用。一项血流动力学研究]
Minerva Med. 1986 Mar 24;77(12):429-32.
9
Beta blockers in cirrhosis: The window re-opens.肝硬化中的β受体阻滞剂：机会再次出现。
J Hepatol. 2016 Mar;64(3):532-4. doi: 10.1016/j.jhep.2015.12.012. Epub 2015 Dec 24.
10
Con: Primary prophylaxis for patients with small esophageal varices from cirrhosis: let the buyer beware.反对意见：对肝硬化所致小食管静脉曲张患者进行一级预防：购买者需谨慎。
Am J Gastroenterol. 2009 Sep;104(9):2134-6. doi: 10.1038/ajg.2009.449.

引用本文的文献

1
Tracking the trajectory of kidney dysfunction in cirrhosis: the acute kidney injury: chronic kidney disease spectrum.追踪肝硬化患者肾功能不全的轨迹：急性肾损伤-慢性肾病谱
Clin Mol Hepatol. 2025 Jul;31(3):730-752. doi: 10.3350/cmh.2024.1060. Epub 2025 Mar 26.
2
Update on the Complications and Management of Liver Cirrhosis.肝硬化并发症与管理的最新进展
Med Sci (Basel). 2025 Feb 5;13(1):13. doi: 10.3390/medsci13010013.
3
The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension.
普萘洛尔对肝硬化伴显著门脉高压患者胃肠动力和通透性的影响。
BMC Gastroenterol. 2024 Nov 21;24(1):420. doi: 10.1186/s12876-024-03483-6.
4
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis.经颈静脉肝内门体分流术可使失代偿期肝硬化患者的全身炎症持续逆转。
Clin Mol Hepatol. 2025 Jan;31(1):240-255. doi: 10.3350/cmh.2024.0587. Epub 2024 Nov 21.
5
Impact of beta-blocker usage on delirium in patients with sepsis in ICU: a cross-sectional study.β受体阻滞剂的使用对重症监护病房脓毒症患者谵妄的影响：一项横断面研究。
Front Med (Lausanne). 2024 Sep 13;11:1458417. doi: 10.3389/fmed.2024.1458417. eCollection 2024.
6
Ascites affects the benefit of carvedilol on patients with liver cirrhosis and esophageal and gastric varices.腹水影响卡维地洛对肝硬化伴食管和胃静脉曲张患者的获益。
Clin Transl Sci. 2024 Jul;17(7):e13889. doi: 10.1111/cts.13889.
7
Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities.肝硬化性心肌病的治疗方法：现状与未来可能。
Int J Mol Sci. 2024 May 28;25(11):5849. doi: 10.3390/ijms25115849.
8
Safety of Nonselective Beta-Blockers in Decompensated Liver Cirrhosis and Their Role in Inducing Hepatorenal Syndrome.非选择性β受体阻滞剂在失代偿期肝硬化中的安全性及其在诱发肝肾综合征中的作用
Cureus. 2024 Apr 15;16(4):e58296. doi: 10.7759/cureus.58296. eCollection 2024 Apr.
9
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting.肝硬化患者的急性肾损伤：急性疾病质量倡议 (ADQI) 和国际腹水俱乐部 (ICA) 联合多学科共识会议。
J Hepatol. 2024 Jul;81(1):163-183. doi: 10.1016/j.jhep.2024.03.031. Epub 2024 Mar 26.
10
Review on Kidney-Liver Crosstalk: Pathophysiology of Their Disorders.肝肾相互作用综述：其疾病的病理生理学
Cell J. 2024 Feb 1;26(2):98-111. doi: 10.22074/cellj.2023.2007757.1376.